Generics 6

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Fampridine manufacturers

6 products found

Filters

6 products found

fampridine

Tablets, extended release (ER) 10 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Albania , Andorra , Austria , Belarus , Belgium , Bosnia And Herzegovina , Bulgaria , Croatia , Cyprus , Czech Republic , France , Germany , Greece , Hungary , Italy , Kosovo , Liechtenstein , Luxembourg , North Macedonia , Malta , Montenegro , Moldova , Monaco , Netherlands , Poland , Portugal , Romania , Russia , Serbia , San Marino , Slovakia , Slovenia , Spain , Switzerland , Ukraine
Available for
Licensing with supply, Distribution only
Comments
PATENT EXPIRY: Q3 2026
Manufacturer #573
A pharmaceutical manufacturer based in the EU that has been active in 50+ countries selling its products in Europe, North America, LATAM, Africa, and Asia for 30+ years. Key production lines are Rx and nutraceuticals. Main therapeutic areas include CNS and respiratory. Main dosage forms include sterile forms and oral solid. The company's production lines are EU GMP-compliant. The company owns 10+ branches in Europe.

Manufacturer usually replies in 7 days

fampridine

Tablets, film coated 10 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Fampyra®
Manufacturer #252

Manufacturer usually replies in 4 days

fampridine

Tablets, extended release (ER) 10mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Manufacturer #16199
One of the largest and biggest names in the pharmaceutical industry. The company has a network all across the globe. They are known to be partnering with similar companies for a very long time.

Manufacturer usually replies in 9 days

Want to see all 6 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Fampridine Manufacturers

Potassium channel blocker fampridine (dalfampridine) is a prescription medication that helps people with multiple sclerosis walk more easily. It is not known to be safe or efficient in children under the age of 18. This is the first medicine that has been approved particularly to help these people with movement. On January 22, 2010, the FDA gave its approval. The potassium channels revealed in multiple sclerosis patients are its therapeutic focus. The QTc interval is not prolonged. It belongs to the drug class miscellaneous central nervous system agents.

How does Fampridine Work?

Axons become increasingly demyelinated in multiple sclerosis, exposing potassium channels. As a result, potassium ions leak out, causing cells to repolarize and neural excitability to diminish. Overall, neuronal transmission is harmed because triggering an action potential is more difficult. In the CNS, dalfampridine blocks voltage-gated potassium channels, allowing the transmembrane potential to be maintained and the activation potential to be prolonged. It targets nerve fibers damaged by multiple sclerosis. It increased mobility in more than 30% of people with multiple sclerosis in clinical investigations. This medicine, in other words, ensures that the potential available is sufficient to drive conduction in myelin sheath axons revealed in patients with multiple sclerosis. Furthermore, it relieves conduction blockages in demyelinated axons, allowing for easier neuromuscular and synaptic communication.

Price of Fampridine

This medicine is available at a variety of prices from a variety of manufacturers and distributors. For a supply of 60 tablets of Fampridine oral tablet, extended-release 10 mg, the price is roughly $3,364. depending on the drugstore you go to. When using this medicine, the directions on the label must be followed to the letter.

Navigating our Pharmaceutical Marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Fampridine offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial multiple sclerosis. The advanced filters help you filter out the countries for Fampridine manufacturers and Fampridine suppliers that you are looking for. These also enable you to check the dossier status of this medicine, and the GMP approvals of the different variants of Fampridine. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Fampridine is already registered in. Manufacturers also have special, and deliver multiple sclerosis.

Establishing Commercial Ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are boarded on the platform. This allows us to screen Fampridine manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation